文丘里联合MR850在气管切开脱机患者中的应用
研究纳入2016年6月至2017年12月山西省汾阳医院气管切开后未行机械通气的成人患者80例,随机分为观察组和对照组各40例。观察组给予文丘里(去面罩)联合MR850装置主动加温湿化氧疗,对照组给予一次性普通流量装置联合热湿交换器(人工鼻,HME)被动湿化氧疗,观察氧疗后5天内体温升高、白细胞计数升高、氧合指数、气道黏膜出血、肺部感染及痰液黏稠度。结果显示观察组体温升高(5.0% vs. 20.0%)、白细胞升高(7.5% vs. 35.0%)、低氧合指数(2.5% vs. 7.5%)、气道黏膜出血(5.0% vs. 15.0%)及肺部感染(2.5% vs. 10.0%)发生率均显著低于对照组(均P<0.01),痰液黏稠度I度患者比例显著高于对照组(57.5% vs. 12.5%,P<0.01)。作者认为该方案可有效控制气道温湿度、促进痰液稀释与引流、减少肺部感染。
要点
- 气管切开脱机成人用文丘里(去面罩)联合MR850主动加温湿化氧疗5天,体温升高发生率5.0% vs 对照组20.0%(P<0.01)。
- 观察组白细胞升高发生率7.5% vs 对照组35.0%,低氧合指数(PaO2/FiO2<300 mmHg)发生率2.5% vs 7.5%,均P<0.01。
- 观察组气道黏膜出血发生率5.0% vs 对照组15.0%,肺部感染发生率2.5% vs 10.0%,均P<0.01。
- 观察组痰液黏稠度I度患者比例57.5% vs 对照组12.5%(P<0.01),提示痰液稀释更充分。
- 作者认为该主动加温湿化方案有利于气管切开脱机患者气道管理并减少术后并发症。
适用人群与场景
- ≥18岁、气管切开后未行机械通气的成人患者,2016年6月至2017年12月于山西省汾阳医院住院。
诊断标准与关键阈值
- 氧疗后5天内观察指标:体温较基础体温升高1℃以上、白细胞计数较基础值升高2×10^9/L、氧合指数(PaO2/FiO2)<300 mmHg(1 mmHg=0.133 kPa)、气道黏膜出血、肺部感染及痰液黏稠度。
处置流程与药物剂量
- 观察组:文丘里(去除面罩)联合MR850装置行主动加温湿化氧疗。
- 对照组:一次性普通流量装置联合热湿交换器(人工鼻,HME)行被动湿化氧疗。
红旗征与不能漏的情况
- 体温较基础体温升高1℃以上。
- 白细胞计数较基础值升高2×10^9/L。
- 氧合指数(PaO2/FiO2)<300 mmHg。
- 气道黏膜出血。
- 肺部感染。
研究设计与关键结果
- 随机对照研究,纳入80例气管切开后未行机械通气的成人患者,观察组与对照组各40例;患者男46例、女34例,平均年龄(67.7±12.2)岁。
- 观察组 vs 对照组:体温升高发生率5.0% vs 20.0%,白细胞升高发生率7.5% vs 35.0%,低氧合指数发生率2.5% vs 7.5%,气道黏膜出血发生率5.0% vs 15.0%,肺部感染发生率2.5% vs 10.0%,均P<0.01。
- 观察组痰液黏稠度I度患者比例57.5% vs 对照组12.5%,P<0.01。
证据类型、等级与局限
- 研究类型:随机对照研究(按随机数字表法分组)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,文丘里联合MR850装置可有效控制气道温湿度、促进痰液稀释和引流、减少气管切开脱机成人患者肺部感染,从而减少气管切开术后并发症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of oxygen therapy with Venturi combined with MR850 heating humidifier on patients without mechanical ventilation after tracheotomy.
METHODS: Eighty patients (≥ 18 years old) who had undergone tracheotomy and without mechanical ventilation admitted to Fenyang Hospital of Shanxi Province from June 2016 to December 2017 were enrolled, and they were divided into control group and observation group according to random number table method, with 40 patients in each group. The observation group was given Venturi (removed the mask) combined with MR850 device active warm and humid oxygen therapy; the control group was given one-off ordinary flow device and warm and humid exchanger (artificial nose, HME) passive humid oxygen therapy. Body temperature increased by 1 centigrade above basal body temperature, white blood cell count (WBC) increased 2×109/L than the base value, oxygenation index (PaO2/FiO2) < 300 mmHg (1 mmHg = 0.133 kPa), airway mucosal hemorrhage, pulmonary infection and sputum viscosity were observed in the two groups for 5 days after oxygen therapy.
RESULTS: Among the 80 patients, there were 46 males and 34 females, with an average age of (67.7±12.2) years. Compared with the control group, the incidence of increased body temperature (5.0% vs. 20.0%), the incidence of increased WBC (7.5% vs. 35.0%), the incidence of low PaO2/FiO2 (2.5% vs. 7.5%), the incidence of airway mucosal bleeding (5.0 % vs. 15.0%) and the incidence of pulmonary infection (2.5% vs. 10.0%) were significantly decreased in the observation group (all P < 0.01), and the proportion of sputum viscosity I degree of patients was significantly increased (57.5% vs. 12.5%, P < 0.01).
CONCLUSIONS: Venturi combined with MR850 device can effectively control airway temperature and humidity, promote sputum dilution and conducive to drainage, reduce pulmonary infection in adults patients without mechanical ventilation after tracheotomy, thereby reducing postoperative complications of tracheotomy.
参考来源
- Guo R, Wang Y, Wang Y, et al. [Application of Venturi combined with MR850 in ventilator offline patients with tracheotomy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439313. doi:10.3760/cma.j.issn.2095-4352.2018.010.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。